Source: Eur Respir J, 53 (6) 1900765; 10.1183/13993003.00765-2019



Rating:

Share or cite this content

Citations should be made in the following way:
Grace Oscullo Yepez, Jesus María Sierra-Párraga, Tomás Posadas Blazquez, Miguel Ángel Martínez-García. Towards precision medicine in bronchiectasis: what is the role of neutrophilic elastase determination?. Eur Respir J, 53 (6) 1900765; 10.1183/13993003.00765-2019

Member's Comments

No comment yet.

Related content which might interest you: Importance of neutrophil elastase in pathogenesis of ALI/ARDS: assessment by bronchoscopic microsampling Source: Annual Congress 2008 - Mechanical ventilation and airway management Year: 2008 Eosinophils: a biological marker for bronchiectasis exacerbations? Source: International Congress 2019 – Phenotypes and endotypes of bronchiectasis Year: 2019 Neutrophil dysfunction in bronchiectasis: an emerging role for immunometabolism Source: Eur Respir J, 58 (2) 2003157; 10.1183/13993003.03157-2020 Year: 2021 Pathogenesis of idiopathic pulmonary fibrosis: role of neutrophil inflammation Source: Eur Respir J 2006; 28: Suppl. 50, 102s Year: 2006 Comparison of different techniques to evaluate active neutrophil elastase in sputum of bronchiectasis and cystic fibrosis patients Source: International Congress 2019 – Complex respiratory infections in clinical practice Year: 2019 Effects of a neutrophil elastase inhibitor against mediators of acute exacerbation of pulmonary fibrosis: a new therapeutic strategy Source: Annual Congress 2008 - New therapeutic strategies in idiopathic pulmonary fibrosis Year: 2008 Making the case for causality: what role do lung microbiota play in idiopathic pulmonary fibrosis? Source: Eur Respir J, 55 (4) 2000318; 10.1183/13993003.00318-2020 Year: 2020 A point of care neutrophil elastase activity assay identifies bronchiectasis severity, airway infection and risk of exacerbation Source: International Congress 2019 – Advances in bronchiectasis and non-TB mycobacterial infections Year: 2019 A point-of-care neutrophil elastase activity assay identifies bronchiectasis severity, airway infection and risk of exacerbation Source: Eur Respir J, 53 (6) 1900303; 10.1183/13993003.00303-2019 Year: 2019 Association of sputum chitinase like protein levels with pathophysiology and neutrophilic airway inflammation in asthma Source: Annual Congress 2008 - Invasive and noninvasive measurements of lung inflammation Year: 2008 α1-Antitrypsin inhalation reduces airway inflammation in cystic fibrosis patients Source: Eur Respir J 2007; 29: 240-250 Year: 2007 Predictive role of neutrophil elastase in the follow-up of patients with interstitial lung diseases Source: Eur Respir J 2001; 18: Suppl. 33, 409s Year: 2001 Neutrophil elastase levels in sputum of patients with different airway diseases: COPD, bronchiectasis and asthma Source: Eur Respir J 2002; 20: Suppl. 38, 95s Year: 2002 The role of polymorphonuclear neutrophil leucocytes in the development of bronchial hyperreactivity in chronic obstructive pulmonary disease Source: Annual Congress 2008 - Respiratory structure and function Year: 2008 Neutrophil elastase increases ciliary beat frequency ex-vivo: implications for the bronchiectasis airway Source: International Congress 2018 – The global impact of bronchiectasis and nontuberculous mycobacteria (NTM) Year: 2018 Sputum: ready for clinical applications? Source: Annual Congress 2005 - PG6 - New and old methodologies to assess pathobiological markers in the lung and airways: from research into clinical practice Year: 2005 Pulmonary eosinophilic syndromes characterization. The role of peripheral eosinophilia as a marker of clinical evolution Source: Annual Congress 2012 - Diffuse parenchymal lung disease II Year: 2012 Neutrophilic inflammation predisposes to structural lung disease in cystic fibrosis (CF) via neutrophil elastase activity Source: Annual Congress 2009 - Cystic fibrosis: disease progression and novel therapies Year: 2009 Proteinase-3 as a biomarker of exacerbations in bronchiectasis. Source: Virtual Congress 2020 – New investigations of bronchiectasis and non-tuberculous mycobacteria Year: 2020